Study of Cannabinoid Receptor Genes and Methamphetamine Dependence
Author Information
Author(s): Okahisa Y, Kodama M, Takaki M, Inada T, Uchimura N, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, Ujike H
Primary Institution: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hypothesis
Is there an association between the CNR1 and CNR2 genes and methamphetamine dependence?
Conclusion
The study suggests that genetic variants of the CNR1 gene may influence the onset of psychosis after methamphetamine abuse, but not dependence itself.
Supporting Evidence
- Patients with the T allele of rs806379 showed a shorter latency to onset of psychosis after methamphetamine use.
- The study included a large sample size of 515 participants.
- Genotyping was performed using TaqMan technology and PCR methods.
- The findings suggest a genetic influence on the clinical course of methamphetamine psychosis.
Takeaway
This study looked at how certain genes might affect people who use methamphetamine, finding that one gene could make it more likely for someone to have psychosis after using the drug.
Methodology
The study involved genotyping SNPs in the CNR1 and CNR2 genes in patients with methamphetamine dependence and matched controls.
Potential Biases
Potential type I errors due to marginal p-values.
Limitations
The findings need confirmation in larger samples and may be affected by population differences.
Participant Demographics
224 patients (178 males, 46 females, average age 37.0) and 292 controls (228 males, 64 females, average age 37.2), all Japanese.
Statistical Information
P-Value
0.040
Statistical Significance
p=0.040
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website